Fehm, T., Mueller, V., Banys-Paluchowski, M., Fasching, P. A., Friedl, T. W. P., Hartkopf, A., . . . Janni, W. (2024). Efficacy of Lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - the DETECT III clinical trial. Clinical chemistry, 70(1), . https://doi.org/10.1093/clinchem/hvad144
Chicago-Zitierstil (17. Ausg.)Fehm, Tanja, et al. "Efficacy of Lapatinib in Patients with HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells - the DETECT III Clinical Trial." Clinical Chemistry 70, no. 1 (2024). https://doi.org/10.1093/clinchem/hvad144.
MLA-Zitierstil (9. Ausg.)Fehm, Tanja, et al. "Efficacy of Lapatinib in Patients with HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells - the DETECT III Clinical Trial." Clinical Chemistry, vol. 70, no. 1, 2024, https://doi.org/10.1093/clinchem/hvad144.